Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2000
10/26/2000WO2000062744A2 Skin care compositions containing combination of skin care actives
10/26/2000WO2000062743A2 Skin care compositions containing combination of skin care actives
10/26/2000WO2000062742A2 Methods for regulating the condition of mammalian keratinous tissue
10/26/2000WO2000062740A2 Skin care compositions containing combination of skin care actives
10/26/2000WO2000062736A2 Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) and surfactant depletion
10/26/2000WO2000062735A2 Treatment of neoplasms with viruses
10/26/2000WO2000062657A2 Improvement of t cell mediated immunity
10/26/2000WO2000062626A1 Method for reducing a susceptibility to tumor formation induced by 3-deoxyglucosone and precursors thereof
10/26/2000WO2000062616A1 (s)-enantiomer enriched fipronil composition
10/26/2000WO2000062614A1 Therapeutic mixture useful in inhibiting lesion formation after vascular injury
10/26/2000WO2000039275A3 Multiple shear stress responsive elements (ssre) and methods of use thereof
10/26/2000WO2000039120A3 Compounds and methods for modulation of estrogen receptors
10/26/2000WO2000039082A3 1,2-annelated quinoline derivatives
10/26/2000WO2000038695A3 Aciclovir compositions containing dimethicone
10/26/2000WO2000037064A3 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
10/26/2000WO2000037061A3 cGMP PDE 5 INHIBITORS FOR INHALATION IN THE TREATMENT OF SEXUAL DYSFUNCTION
10/26/2000WO2000035919A3 Quinoline derivatives
10/26/2000WO2000035886A3 (hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors
10/26/2000WO2000035865A3 Tubulin-binding agents
10/26/2000WO2000035441A3 Pharmaceutical aerosol formulations containing fluoroalkanes, budesonide and formoterol
10/26/2000WO2000034294A3 Tumor necrosis factor receptor homologue-1 ('trh1')
10/26/2000WO2000032188A3 Use of amtolmetin guacyl as an antiinflammatory drug
10/26/2000WO2000031120A3 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis
10/26/2000WO2000027815A3 N-substituted azacycles, their preparation and their use as orl-1 receptor ligands
10/26/2000WO2000026385A9 Nucleic acid constructs for genetic immunization
10/26/2000WO2000026197A9 Novel inhibitors of impdh enzyme
10/26/2000WO2000025746A3 A process for the preparation of suspensions of drug particles for inhalation delivery
10/26/2000WO2000021508A3 Novel therapeutic use of compounds with beta-3-agonist activity
10/26/2000WO2000020601A3 Polyketide synthase enzymes and recombinant dna constructs therefor
10/26/2000WO2000018230A9 Combination of bisphosphonate and tetracycline
10/26/2000WO2000017191A3 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
10/26/2000WO2000017190A3 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
10/26/2000WO2000013675A9 Methazolamide compositions and method of use
10/26/2000WO2000007577A3 Phosphatidylcholine as a medicament for the protection of mucosa
10/26/2000WO2000006206A9 Compositions and methods for the treatment and diagnosis of cardiovascular disease
10/26/2000WO2000006151A9 Sustained release nitric oxide producing agents
10/26/2000WO2000004012A9 COMPOUNDS SPECIFIC FOR THE HUMAN α1d ADRENERGIC RECEPTOR AND USES THEREOF
10/26/2000WO1999062876A9 24,24-difluorinated analogs of 1-alpha,25-dihydroxy vitamin d3
10/26/2000WO1999021558A3 Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
10/26/2000DE19918644A1 Intradermal composition for local treatment of skin aging or wrinkles, comprising matrix containing estrogen and structure former to minimize systemic side-effects
10/26/2000DE19918434A1 Storage-stable solid proton pump inhibitor formulation useful e.g. for treating duodenal ulcers, comprises amorphous active agent embedded in auxiliary matrix
10/26/2000DE19918365A1 New nucleic acid encoding flavone synthase II, useful e.g. for producing transgenic plants with altered flower color or flavone content
10/26/2000DE19918325A1 Extruded drug dosage form, e.g. granulate for tableting, comprising an active agent in a polysaccharide-containing matrix, giving a release profile which is controllable by extrusion conditions and/or the inclusion of additives
10/26/2000DE19918324A1 Bactericidal, virucidal, fungicidal and antiprotozoal pharmaceutical composition, especially for ophthalmological use, contains benzalkonium salt
10/26/2000DE19918211A1 New 2-carbocyclyl-benzimidazole-carboxamide derivatives, are PARP inhibitors useful e.g. for treating neurodegenerative disease, epilepsy, ischemia, tumors, inflammation or diabetes
10/26/2000DE19918106A1 Transdermal patches containing basic or neutral drug include adhesive (meth)acrylic acid polymer in alkali(ne earth) metal salt form
10/26/2000DE19917906A1 Verwendung von aminosubstituierten Hydroxybenzophenonen als photostabile UV-Filter in kosmetischen und pharmazeutischen Zubereitungen The use of amino-substituted hydroxybenzophenones as photostable UV filters in cosmetic and pharmaceutical preparations
10/26/2000DE19917548A1 Stable topical pharmaceutical composition for treating skin diseases, especially acne, contains erythromycin higher fatty acid salt in liquid or viscous carrier
10/26/2000DE19860802A1 Herstellung eines Mittels gegen Hepatitis B-, HI-, Paramyxo und Orthomyxo-Viren Production of an agent against hepatitis B, HI, and Paramyxo orthomyxovirus viruses
10/26/2000DE10017883A1 Neues Behandlungsverfahren New treatment methods
10/26/2000CA2382036A1 Novel pharmaceutical
10/26/2000CA2379105A1 An oral formulation for ileum administering comprising an inhibitor compound of the ileal bile acid transport
10/26/2000CA2371972A1 Ent-steroids as selectively active estrogens
10/26/2000CA2371942A1 Pseudomycin antifungal compositions and methods for their use
10/26/2000CA2371399A1 Skin care compositions containing combination of skin care actives
10/26/2000CA2371389A1 Beta-lactamase inhibiting 7-alkyldiene cephalosporanic acid derivatives
10/26/2000CA2370743A1 Ketolide antibacterials
10/26/2000CA2370742A1 Ppar-(gamma) agonists as agents for the treatment of type ii diabetes
10/26/2000CA2370721A1 Neurotrophin potentiators
10/26/2000CA2370713A1 Salts of asiatic and madecassic acid suitable for the preparation of pharmaceutical and cosmetic compositions
10/26/2000CA2370690A1 Cationic peg-lipids and methods of use
10/26/2000CA2370659A1 The p2x3 receptor, methods of altering p2x3 receptor activity and uses thereof
10/26/2000CA2370628A1 Methods and compositions for inhibiting the function of polynucleotide sequences
10/26/2000CA2370419A1 Cobalamin conjugates useful as antitumor agents
10/26/2000CA2370417A1 Substituted azoles
10/26/2000CA2370401A1 Novel polymorphic forms of an antidiabetic agent: process for their preparation and pharmaceutical compositions containing them
10/26/2000CA2370296A1 Improvement of t cell mediated immunity
10/26/2000CA2370273A1 Novel 8a- and 9a-15-membered lactams
10/26/2000CA2370270A1 Novel pharmaceutical
10/26/2000CA2370268A1 Treatment of adult rheumatoid arthritis by oral administration of pooled human immunoglobulin and an antacid
10/26/2000CA2370231A1 Haloalkoxy imidazonaphthyridines
10/26/2000CA2370197A1 Methods for regulating the condition of mammalian keratinous tissue
10/26/2000CA2370146A1 Ruthenium dimeric complexes suitable as antimetastatic and antineoplastic agents
10/26/2000CA2370129A1 Methods and compositions for modulating an immune response
10/26/2000CA2370127A1 Novel method of treatment
10/26/2000CA2370126A1 Estrogen receptor-.beta. ligands
10/26/2000CA2369886A1 Macrolide antiinfective agents
10/26/2000CA2369820A1 Nucleic acids encoding cd40/cd40l chimeric polypeptides, methods for their production and uses thereof
10/26/2000CA2369816A1 Macrolide antiinfective agents
10/26/2000CA2369772A1 A therapeutic mixture useful in inhibiting lesion formation after vascular injury
10/26/2000CA2369762A1 A method for improving the half-life of soluble viral-specific ligands on mucosal membranes
10/26/2000CA2369755A1 Method for reducing a susceptibility to tumor formation induced by 3-deoxyglucosone and precursors thereof
10/26/2000CA2369633A1 A multi-plasmid method for preparing large libraries of polyketides and non-ribosomal peptides
10/26/2000CA2369126A1 Use of ap-1 activators to treat glaucoma and ocular hypertension
10/26/2000CA2369078A1 Medicaments containing inhibitors of cell-volume regulated human kinase h-sgk
10/26/2000CA2368815A1 Novel synthesis and crystallization of piperazine ring-containing compounds
10/26/2000CA2368784A1 Methods of treating clinical diseases with isoflavones
10/26/2000CA2368029A1 Pharmaceutical composition comprising pim-activated nkt cells, and therapeutic use thereof
10/26/2000CA2367367A1 (-)-verbenone derivatives
10/26/2000CA2367359A1 Dibenzoazulene derivatives for the treatment of thrombosis, osteoporosis, arteriosclerosis
10/26/2000CA2367356A1 New compounds, their preparation and use
10/26/2000CA2365579A1 Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (rsv)
10/26/2000CA2365523A1 Identification of sortase gene
10/26/2000CA2365449A1 Inhibitor of the growth of androgen-independent tumor
10/26/2000CA2364209A1 49 human secreted proteins
10/26/2000CA2363994A1 Diagnosis of a person's risk for developing atherosclerosis or diabetic retinopathy
10/26/2000CA2363945A1 Novel ribose-substituted aromatic amides, method for the production and use thereof as medicaments
10/26/2000CA2363689A1 Compounds useful as phosphotyrosine mimics
10/26/2000CA2330231A1 Composition and method for modulating dendritic cell-t cell interaction
10/26/2000CA2330022A1 Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) and surfactant depletion
1 ... 6221 6222 6223 6224 6225 6226 6227 6228 6229 6230 6231 6232 6233 6234 6235 6236 6237 6238 6239 6240 6241 ... 7860